Skip to Content

734 Endo (Mycophenolate Mofetil 250 mg)

Pill with imprint 734 Endo is Blue & Orange, Capsule-shape and has been identified as Mycophenolate Mofetil 250 mg. It is supplied by Endo Pharmaceuticals Inc..

Mycophenolate mofetil is used in the treatment of nephrotic syndrome; organ transplant, rejection prophylaxis; graft-versus-host disease and belongs to the drug class selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Mycophenolate mofetil 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 734 Endo

Mycophenolate Mofetil

Imprint
734 Endo
Strength
250 mg
Color
Blue & Orange
Size
19.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Selective immunosuppressants
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Endo Pharmaceuticals Inc.
National Drug Code (NDC)
60951-0734
Inactive Ingredients
ammonia, croscarmellose sodium, magnesium stearate, microcrystalline cellulose, potassium hydroxide, povidone, propylene glycol, shellac, ferric oxide yellow, FD&C Blue No. 2, ferric oxide red, ferrosoferric oxide, FD&C Red No. 3

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.